Browse > Article
http://dx.doi.org/10.5352/JLS.2010.20.8.1276

Effect of Berberine on the Proinflammatory Cytokines Production in Mice  

Chung, Su-Ryoung (Department of Internal Medicine, Dong Eui Medical Center, Dong Eui University)
Choi, Myung-Won (Department of Microbiology, Kosin University College of Medicine)
Park, In-Dal (Department of Microbiology, Kosin University College of Medicine)
Kim, Kwang-Hyuk (Department of Microbiology, Kosin University College of Medicine)
Publication Information
Journal of Life Science / v.20, no.8, 2010 , pp. 1276-1280 More about this Journal
Abstract
Berberine has shown a number of beneficial effects, including anti-tumor, anti-inflammation, and vasodilatory effects. In this work we investigated the effects of berberine on the production of proinflammatory cytokines such as TNF-$\alpha$, IL-$1{\beta}$, and IL-6 in mice. The supernatants of cultured splenocytes exposed with berberine or berberine plus LPS were harvested to assay TNF-$\alpha$, IL-$1{\beta}$, and IL-6. The sera from the mice injected with berberine or berberine plus LPS were then isolated to assay these cytokines. The TNF-$\alpha$ production in mice splenocyte cultures exposed to berberine was inhibited compared to the PBS control. The sera from LPS plus berberine injected mice showed lower levels of TNF-$\alpha$ compared to those of LPS only injected mice. The IL-$1{\beta}$ production in mice splenocyte cultures exposed to berberine was inhibited at a high dose (3.0 ${\mu}g/ml$) compared to the PBS control. Also, the increase of IL-$1{\beta}$ by LPS exposure in splenocyte cultures was inhibited by a high dose of berberine. The IL-6 in splenocyte culture supernatants showed lower levels after berberine compared to the PBS control. Also, production of IL-6 after LPS exposure in splenocyte cultures was inhibited by a low dose of berberine (0.3 ${\mu}g/ml$). These findings suggest the probability that berberine down-regulates the production of proinflammatory cytokines such as TNF-$\alpha$, IL-$1{\beta}$, and IL-6.
Keywords
Berberine; TNF-$\alpha$; IL-$1{\beta}$; IL-6; mice;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Anis, K. V., N. V. Rajeshkumar, and R. Kuttan. 2001. Inhibition of chemical carcinogenesis by berberine in rat and mice. J. Pharm. Pharmacol. 53, 763-768.   DOI
2 Creasey, W. A. 1979. Biochemical effects of berberine. Biochem. Pharmacol. 28, 1081-1084.   DOI
3 Iizuka, N., K. Miyamoto, K. Okita, A. Tangoku, H. Hayashi, S. Yoshino, T. Abe, T. Morioka, S. Hazama, and M. Oka. 2000. Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines. Cancer Lett. 148, 19-25.   DOI
4 Iizuka, N., K. Miyamoto, S. Hazama, S. Yoshino, K. Yoshimura, K. Okida, T. Hukumoto, S. Yamamoto, A. Tangoku, and M. Oka. 2000. Anticachectic effect of Coptidis rhizoma, an antiinflammatory herb, on esophageal cancer cells that produce interleukin 6. Cancer Lett. 158, 35-41.   DOI
5 Zhao, W., Z. X. Zhou, W. J. Kong, and J. D. Jiang. 2008. Reduction of blood lipid by berberine in hyperlipidemic patients with chronic hepatitis or liver cirrhosis. Biomed. Pharmacother. 62, 730-731.   DOI
6 Sun, Y., K. Xun, Y. Wang, and X. Chen. 2009. A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs 20, 757-769.   DOI   ScienceOn
7 Lee, C. H., J. C. Chen, C. Y. Hsiang, S. L. Wu, H. C. Wu, and T. Y. Ho. 2007. Berberine suppresses inflammatory agents-induced interleukin-1$\beta$ and tumor necrosis factor-$\alpha$ productions via the inhibition of I$\kappa$B degradation in human lung cells. Pharmacol. Res. 56, 193-201.   DOI
8 Liu, Y., H. Yu, C. Zhang, Y. Cheng, L. Hu, X. Meng, and Y. Zhao. 2008. Protective effects of berberine on radiation-induced lung injury via intercellular adhesion molecular-1 and transforming growth factor-beta-1 in patients with lung cancer. Eur. J. Cancer 44, 2425-2432.   DOI
9 Marinova, E. K., D. B. Nikolova, D. N. Popova, G. B. Gallacher, and N. D. Ivanovska. 2000. Suppression of experimental autoimmune tubulointerstitial nephritis in BALB/C mice by berberine. Immunopharmacol. 48, 9-16.   DOI
10 Shvarev, I. F. and A. L. Tsetlin. 1972. Anti-blastic properties of berberine and its derivatives. Farmakol. Toksikol. 35, 73-75.
11 Xu, Y., Y. Wang, and L. Yan. 2009. Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans: endogenous ROS augmentation. J. Proteome Res. 8, 5296-5304.   DOI
12 Yin, J., H. L. Xing, and J. P. Ye. 2008. Efficacy of berberine in patients with type 2 diabetes mellitus. Metab. Clin. Exp. 57, 712-717.   DOI   ScienceOn
13 Yu, H. H., K. J. Kim, J. D. Cha, H. K. Kim, Y. E. Lee, N. Y. Choi, and Y. O, You. 2005. Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus. J. Med. Food 8, 454-461.   DOI
14 Ikram, M. 1975. A review on the chemical and pharmacological aspects of genus Berberis. Planta Med. 28, 353-358.   DOI
15 Ivanovska, N. and S. Phillip. 1996. Study on the anti-inflammatory of Berveris vulgaris root extract, alkaloid fractions and pure alkaloids. Int. J. Immunopharmacol. 18, 553-561.   DOI
16 Kim, S. M., Y. Kim, J. E. Kim, K. H. Cho, and J. H. Chung. 2008. Berberine inhibits TPA-induced MMP-9 and IL-6 expression in normal human keratinocytes. Phytomedicine 15, 340-347.   DOI
17 Jantova, S., L. Cipak, M. Cernakova, and D. Kost'alova. 2003. Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells. J. Pharm. Pharmacol. 55, 1143-1149.   DOI
18 Kallapur, S. G. and A. H. Jobe. 2006. Contribution of inflammation to lung injury and development. Arch. Dis. Child. Fetal Neonatal. 91, 132-135.   DOI
19 Kettmann, V., D. Kosfalova, S. Jantova, M. Cernakova, and J. Drimal. 2004. In vitro cytotoxicity of ververine against HeLa and L1210 cancer cell lines. Pharmazie 59, 548-551.
20 Kong, W. J., Z. Y. Zuo, Y. M. Wang, D. Q. Song, X. F. You, L. X. Zhao, H. N. Pan, and J. D. Jiang. 2008. Combination of simvastatin with berberine improves the lipid-lowering efficacy. Metab. Clin. Exp. 57, 1029-1037.   DOI   ScienceOn
21 Kuo, C. L., C. W. Chi, and T. Y. Liu. 2004. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett. 203, 127-137.   DOI
22 Lau, C. W., X. Q. Yao, Z. Y. Chen, W. H. Ko, and Y. Huang. 2001. Cardiovascular actions of berberine. Cardiovasc. Drug Rev. 19, 234-244.   DOI